SceneRay Receives NMPA Approval for World-First DBS System Targeting Opioid Addiction
In a landmark development for the global neuromodulation market, the National Medical Products Administration (NMPA) has officially granted marketing approval to SceneRay Medical’s Implantable Deep...
The 1st Domestically Developed Invasive BCI Device Got Approved in China
“Mingtong (明瞳）,” a functional neurosurgical electrophysiological recording and stimulation device, has been officially approved for market release by China’s National Medical Products Administration (NMPA). Developed...